Spots Global Cancer Trial Database for estramustine
Every month we try and update this database with for estramustine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer | NCT00151086 | Prostate Cancer | Estramustine Vinorelbine | 18 Years - | University of Michigan Rogel Cancer Center | |
| Efficacy and Safety of Estracyt® in Metastatic Breast Cancer | NCT02853071 | Breast Cancer | Estramustine standard practi... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | NCT00028769 | Prostate Cancer | bicalutamide estramustine etoposide flutamide goserelin leuprolide nilutamide paclitaxel | 18 Years - | SWOG Cancer Research Network | |
| Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | NCT00151060 | Prostate Cancer | Estramustine Etoposide Paclitaxel | 18 Years - | University of Michigan Rogel Cancer Center | |
| Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | NCT00016913 | Prostate Cancer | carboplatin estramustine paclitaxel radiation thera... leuprolide or g... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer | NCT00151086 | Prostate Cancer | Estramustine Vinorelbine | 18 Years - | University of Michigan Rogel Cancer Center | |
| Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | NCT00016913 | Prostate Cancer | carboplatin estramustine paclitaxel radiation thera... leuprolide or g... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma | NCT00038168 | Prostate Cancer | Estramustine Taxol | - | M.D. Anderson Cancer Center | |
| S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00004001 | Prostate Cancer | docetaxel estramustine mitoxantrone prednisone | 18 Years - | SWOG Cancer Research Network | |
| Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer | NCT00193271 | Prostate Cancer | Docetaxel Estramustine | 18 Years - | SCRI Development Innovations, LLC | |
| Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer | NCT02560051 | Prostatic Neopl... | Doxorubicin Ketoconazole Docetaxel Estramustine Degarelix | 18 Years - | The University of Texas Health Science Center, Houston | |
| Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | NCT00003084 | Prostate Cancer | Doxorubicin Hyd... Estramustine ph... Etoposide Ketoconazole Paclitaxel Vinblastine | 18 Years - | M.D. Anderson Cancer Center | |
| S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00004001 | Prostate Cancer | docetaxel estramustine mitoxantrone prednisone | 18 Years - | SWOG Cancer Research Network | |
| Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate | NCT00151073 | Hormone-Refract... | Zoledronic acid Estramustine Docetaxel | 18 Years - | University of Michigan Rogel Cancer Center | |
| Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer | NCT02494713 | Prostate Cancer | Degarelix Doxorubicin Ketoconazole Docetaxel Estramustine | 18 Years - | The University of Texas Health Science Center, Houston | |
| Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer | NCT01250717 | Prostate Cancer | Docetaxel Dexamethasone Estramustine Zoladex Casodex Radical Prostat... | 18 Years - | Dana-Farber Cancer Institute | |
| Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma | NCT00193193 | Prostate Cancer | Paclitaxel Estramustine Carboplatin | 18 Years - | SCRI Development Innovations, LLC | |
| Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer | NCT00541281 | Hormone Resista... Metastatic Pros... | docetaxel estramustine prednisone | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment | NCT00165399 | Adenocarcinoma ... Prostate Cancer | Docetaxel Estramustine Casodex Zoladex | 18 Years - | Dana-Farber Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
